Clarity Science - International Scientific Healthcare Research

“Traditional Allergy Immunotherapy consists of multiple years of Injections (sub-cutaneous immunotherapy- (SCIT)). We now have preliminary evidence that supplying allergens through topical administration shows a decrease in IgE levels and may prove to be a viable alternative to allergy shots and the millions of people who are allergy sufferers. We are conducting more clinical trials and excited to expand on these initial results.”

Peter Hurwitz
President, Clarity Science LLC
Co-Author

Current Scar Study

TARGET

(TopicAl Silicone in RestorinG Scars and Burn Tissue – Evaluating Therapy)

Positive interim TARGET Results have been presented at leading conferences, including the 7th Joint Meeting of the European Tissue Repair Society & the Wound Healing Society held in Copenhagen, Denmark, among others.

ETRS

Results from an interim analysis of our TARGET study (a scar and burn treatment study) show that adults using a prescribed topical scar and burn cream reported:

Reduced scar/burn size as measured by clinicians and as perceived by patients.

Reduced itching.

Reduced scar/burn interference with general activity, mood, sleep, and life enjoyment.

Reduced pain medication use.

VIEW TARGET POSTER SEE TARGET STUDY DETAILS

Closed Pain Study

OPERA

(Optimizing Patient Experience and Response to Topical Analgesics)

Positive interim OPERA Results have been presented at important conferences, including the 4th Annual International Conference on Opioids held at Harvard Medical School, among others.

Opioids harvard medical school
ACRP

Results from an interim analysis of our OPERA study (a pain study) show that patients with musculoskeletal and neuropathic pain using a prescribed topical analgesic reported: